{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:04:55Z","timestamp":1760954695567},"reference-count":26,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.jim.2004.08.017","type":"journal-article","created":{"date-parts":[[2004,10,6]],"date-time":"2004-10-06T14:44:56Z","timestamp":1097073896000},"page":"101-110","source":"Crossref","is-referenced-by-count":28,"title":["Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera"],"prefix":"10.1016","volume":"294","author":[{"given":"W.","family":"Hoesel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Moller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kanne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wessner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gromnica-Ihle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fromme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Haselbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2004.08.017_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mcp.2002.128374","article-title":"Pharmacokinetics and pharmacodynamics of darbepoetin alfa and epoetin in patients undergoing dialysis","volume":"72","author":"Allon","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jim.2004.08.017_bib2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.1997.91","article-title":"EPO in pathogenesis and treatment of the anemia of chronic renal failure","volume":"51","author":"Besarab","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.jim.2004.08.017_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200202143460711","article-title":"Drug-induced autoimmune red-cell aplasia","volume":"346","author":"Bunn","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 5","key":"10.1016\/j.jim.2004.08.017_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/17.suppl_5.42","article-title":"Antibodies against rHuEPO: native and recombinant","volume":"17","author":"Casadevall","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"issue":"Suppl. 8","key":"10.1016\/j.jim.2004.08.017_bib6","first-page":"viii37","article-title":"Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin","volume":"18","author":"Casadevall","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jim.2004.08.017_bib4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM199603073341004","article-title":"Autoantibodies against erythropoietin in a patient with pure red-cell aplasia","volume":"334","author":"Casadevall","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2004.08.017_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","article-title":"Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin","volume":"346","author":"Casadevall","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2004.08.017_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/phrs.1999.0593","article-title":"Detection of anti-erythropoietin antibodies in haemodialysis patients treated with recombinant human-erythropoietin","volume":"41","author":"Castelli","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jim.2004.08.017_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00003495-199651020-00008","article-title":"Epoetin beta. A review of its pharmacological properties and clinical use in the management of anemia associated with chronic renal failure","volume":"51","author":"Dunn","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.jim.2004.08.017_bib10","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJM200205163462015","article-title":"Pure red-cell aplasia and recombinant erythropoietin","volume":"346","author":"Gershon","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2004.08.017_bib11","series-title":"Nonradiactive Labeling and Detection of Biomolecules","first-page":"94","article-title":"Labeling and detection of proteins and glycoproteins","author":"Haselbeck","year":"1999"},{"key":"10.1016\/j.jim.2004.08.017_bib12","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1023\/B:PHAM.0000008034.61317.02","article-title":"Micelle-associated protein in epoetin formulations: a risk factor for immunogenicity?","volume":"20","author":"Hermeling","year":"2003","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jim.2004.08.017_bib13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0090-1229(76)90094-5","article-title":"Rheumatoid factor: its nature, specificity and production in rheumatoid arthritis","volume":"6","author":"Johnson","year":"1976","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jim.2004.08.017_bib14","first-page":"100","article-title":"Methods for measuring erythropoietin and erythropoietin antibodies using ELISA technique","volume":"vol.76","author":"Kientsch-Engel","year":"1989"},{"key":"10.1016\/j.jim.2004.08.017_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1185\/030079903125002414","article-title":"Validation of the BIAcore 3000 platform for detection of antibodies against erythropoietic agents in human serum samples","volume":"19","author":"Mason","year":"2003","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jim.2004.08.017_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/abio.1999.4215","article-title":"Purification of prostate-specific antigen from human serum by indirect immunosorption and elution with a hapten","volume":"273","author":"Peter","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jim.2004.08.017_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.ASN.0000107561.59698.42","article-title":"Anti-erythropoietin antibodies and pure red cell aplasia","volume":"15","author":"Rossert","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jim.2004.08.017_bib18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/rheumatology\/40.4.424","article-title":"Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anemia of systemic lupus erythematosus","volume":"40","author":"Schett","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.jim.2004.08.017_bib19","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1086\/315156","article-title":"Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-related anemia","volume":"180","author":"Sipsas","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2004.08.017_bib20","series-title":"Immunogenicity of Therapeutic Biological Products","first-page":"127","article-title":"New technologies for the detection of antibodies to therapeutic proteins","volume":"vol. 112","author":"Swanson","year":"2003"},{"key":"10.1016\/j.jim.2004.08.017_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000076746","article-title":"Evaluation of methods to detect and characterize antibodies against recombinant human erythropoietin","volume":"96","author":"Swanson","year":"2004","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.jim.2004.08.017_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jim.2003.09.003","article-title":"The detection of anti-erythropoietin antibodies in human serum and plasma: Part I. Validation of the protocol for a radioimmunoprecipitation assay","volume":"283","author":"Tacey","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2004.08.017_bib23","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/art.1780401216","article-title":"Autoantibodies to human erythropoietin in patients with systemic lupus erythematosus: correlation with anemia","volume":"40","author":"Tzioufas","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jim.2004.08.017_bib24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/clinchem\/43.5.848","article-title":"Rapid method for detection of anti-recombinant human erythropoietin antibodies as a new form of erythropoietin resistance","volume":"43","author":"Urra","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jim.2004.08.017_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/ard.59.3.217","article-title":"Anemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin","volume":"59","author":"Voulgarelis","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jim.2004.08.017_bib26","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/01.ASN.0000027031.79843.6C","article-title":"Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins","volume":"13","author":"Weber","year":"2002","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175904003059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175904003059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T08:47:59Z","timestamp":1585903679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175904003059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0022175904003059"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2004.08.017","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}